BioXcel Therapeutics Inc (BTAI)
2.555
+0.02
(+0.59%)
USD |
NASDAQ |
May 02, 16:00
2.555
0.00 (0.00%)
After-Hours: 18:12
BioXcel Therapeutics Debt to Equity Ratio: -1.780 for Dec. 31, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2023 | -1.780 |
| September 30, 2023 | -2.440 |
| June 30, 2023 | 16.52 |
| Date | Value |
|---|---|
| March 31, 2023 | 1.794 |
| December 31, 2022 | 1.212 |
| September 30, 2022 | 0.7221 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-2.440
Minimum
Sep 2023
16.52
Maximum
Jun 2023
2.670
Average
0.967
Median
Debt to Equity Ratio Benchmarks
| Synlogic Inc | 0.00 |
| Cormedix Inc | -- |
| Bristol-Myers Squibb Co | 3.376 |
| Verastem Inc | -- |
| Ocular Therapeutix Inc | 0.8222 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 73.70M |
| Total Liabilities (Quarterly) | 130.21M |
| Shareholders Equity (Quarterly) | -56.51M |
| Current Ratio | 2.646 |
| Net Debt Paydown Yield | -2.02% |